Shatavarin IV

• Target :

  Reactive Oxygen Species|||Others|||ROS

• Related Pathways :

  Metabolism|||Immunology/Inflammation|||Others|||NF-?B

• Bioactivity :

  Shatavarin IV shows in vitro anti-malassezia activity. Shatavarins (containing shatavarin IV) rich fraction (AR-2B) exhibits significant anticancer activity in both in vitro and in vivo experimental models.

• Smiles :

  C[C@@]12[C@@]3([C@](C[C@]1([C@]4([C@](CC2)([C@]5(C)[C@](CC4)(C[C@@H](O[C@H]6[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O[C@H]8[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O8)[C@@H](CO)O6)CC5)[H])[H])[H])[H])(O[C@@]9([C@H]3C)CC[C@H](C)CO9)[H])[H]

• Molecular Formula :

  C45H74O17

• Molecular Weight :

  887.06

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  84633-34-1